Note: You clicked on an external link, which has been disabled in order to keep your shopping session open.
|Tested species reactivity||Human, Mouse, Rat|
|Published species reactivity||Dog, Rat, Human, Mouse|
|Host / Isotype||Mouse / IgG2a|
|Immunogen||Recombinant extracellular domain of rat NDF protein|
|Storage buffer||PBS, pH 7.4, with 0.2% BSA|
|Contains||0.09% sodium azide|
|Storage Conditions||4° C|
|Tested Applications||Dilution *|
|Immunohistochemistry (Paraffin) (IHC (P))||1:25-1:50|
|Immunoprecipitation (IP)||2 µg/ml|
|Western Blot (WB)||1-2 µg/ml|
* Suggested working dilutions are given as a guide only. It is recommended that the user titrate the product for use in their own experiment using appropriate negative and positive controls.
MA5-12893 targets Heregulin in IHC (P), IP, and WB applications and shows reactivity with Human, mouse, and Rat samples. Staining of formalin/paraffin tissues requires boiling tissue sections in 10mM citrate buffer, pH 6.0, for 10-20 minutes followed by cooling at RT for 20 minutes.
The MA5-12893 immunogen is recombinant extracellular domain of rat NDF protein.
Heregulin (HRG) or neu differentiation factor (NDF) binds to c-erbB-3 and c-erbB-4 receptors on mammary and neuronal cells with low and high affinities, respectively. HRG/NDF exists in several isoforms, which are classified in two groups, alpha and beta that differ in their EGF-like domain and in receptor binding affinity.
For Research Use Only. Not for use in diagnostic procedures. Not for resale without express authorization.
Neuregulin-1-human epidermal receptor-2 signaling is a central regulator of pulmonary epithelial permeability and acute lung injury.
MA5-12893 was used in western blot to study the role of neuregulin-1 and HER2 in regulating pulmonary epithelial permeability and acute lung injury
|Finigan JH,Faress JA,Wilkinson E,Mishra RS,Nethery DE,Wyler D,Shatat M,Ware LB,Matthay MA,Mason R,Silver RF,Kern JA||The Journal of biological chemistry (286:10660)||2011|
Phenotypic characterization of transgenic mice overexpressing neuregulin-1.
MA5-12893 was used in western blot to study the cognitive and behavioural phenotype of transgenic mice overexpressing neuregulin-1
|Kato T,Kasai A,Mizuno M,Fengyi L,Shintani N,Maeda S,Yokoyama M,Ozaki M,Nawa H||PloS one (5:null)||2010|
Neuregulin-1 signaling in brain endothelial cells.
MA5-12893 was used in western blot to study neuregulin-1 signaling in brain microvascular endothelial cells
|Lok J,Sardi SP,Guo S,Besancon E,Ha DM,Rosell A,Kim WJ,Corfas G,Lo EH||Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism (29:39)||2009|
Neuregulin-1 enhances survival of human astrocytic glioma cells.
MA5-12893 was used in western blot to study the mechanism by which neuregulin-1 promotes the survival of human astrocytoma cells
|Ritch PS,Carroll SL,Sontheimer H||Glia (51:217)||2005|
Peripheral neuropathy in the twitcher mouse: accumulation of extracellular matrix in the endoneurium and aberrant expression of ion channels.
MA5-12893 was used in immunohistochemistry to investigate the extracellular and protein abnormalities in peripheral neuropathy
|Kagitani-Shimono K,Mohri I,Yagi T,Taniike M,Suzuki K||Acta neuropathologica (115:577)||2008|
Localization of neuregulin-1alpha (heregulin-alpha) and one of its receptors, ErbB-4 tyrosine kinase, in developing and adult human brain.
MA5-12893 was used in immunohistochemistry to study the localization of neuregulin-1alpha and ErbB-4 tyrosine kinase in developing and adult human brain
|Bernstein HG,Lendeckel U,Bertram I,Bukowska A,Kanakis D,Dobrowolny H,Stauch R,Krell D,Mawrin C,Budinger E,Keilhoff G,Bogerts B||Brain research bulletin (69:546)||2006|
NRG1 gene rearrangements in clinical breast cancer: identification of an adjacent novel amplicon associated with poor prognosis.
MA5-12893 was used in immunohistochemistry to investigate the association of NRG1 gene rearrangements with poor prognosis in breast cancer treatment
|Prentice LM,Shadeo A,Lestou VS,Miller MA,deLeeuw RJ,Makretsov N,Turbin D,Brown LA,Macpherson N,Yorida E,Cheang MC,Bentley J,Chia S,Nielsen TO,Gilks CB,Lam W,Huntsman DG||Oncogene (24:7281)||2005|
Expression of heregulin in human coronary atherosclerotic lesions.
MA5-12893 was used in immunohistochemistry to study the expression of heregulin in human coronary atherosclerotic lesions
|Panutsopulos D,Arvanitis DL,Tsatsanis C,Papalambros E,Sigala F,Spandidos DA||Journal of vascular research (42:463)||2005|
Paclitaxel and carboplatin as first-line chemotherapy combined with gefitinib (IRESSA) in patients with advanced breast cancer: a phase I/II study conducted by the Hellenic Cooperative Oncology Group.
MA5-12893 was used in immunohistochemistry to investigate the efficacy of the combination of paclitaxel, carboplatin and gefitinib against advanced breast cancer
|Fountzilas G,Pectasides D,Kalogera-Fountzila A,Skarlos D,Kalofonos HP,Papadimitriou C,Bafaloukos D,Lambropoulos S,Papadopoulos S,Kourea H,Markopoulos C,Linardou H,Mavroudis D,Briasoulis E,Pavlidis N,Razis E,Kosmidis P,Gogas H||Breast cancer research and treatment (92:1)||2005|
Role of neuregulin-1/ErbB2 signaling in endothelium-cardiomyocyte cross-talk.
MA5-12893 was used in immunoprecipitation to study the role of neuregulin-1/ErbB2 signaling in endothelium-cardiomyocyte cross-talk
|Lemmens K,Segers VF,Demolder M,De Keulenaer GW||The Journal of biological chemistry (281:19469)||2006|
Constitutive neuregulin-1/ErbB signaling contributes to human vestibular schwannoma proliferation.
MA5-12893 was used in immunoprecipitation and western blot to study the role of constitutive neuregulin-1/ErbB signaling in human vestibular schwannoma proliferation
|Hansen MR,Roehm PC,Chatterjee P,Green SH||Glia (53:593)||2006|
Back signaling by the Nrg-1 intracellular domain.
MA5-12893 was used in immunocytochemistry to study the bidirectional signaling of neuregulin-1 in neurones and the role of the intracellular domain in retrograde signaling
|Bao J,Wolpowitz D,Role LW,Talmage DA||The Journal of cell biology (161:1133)||2003|
Reciprocal signaling between spiral ganglion neurons and Schwann cells involves neuregulin and neurotrophins.
MA5-12893 was used in immunocytochemistry to study the role of neuregulin and neurotrophins in regulating spiral ganglion neuron-Schwann cell reciprocal signaling in the auditory nerve
|Hansen MR,Vijapurkar U,Koland JG,Green SH||Hearing research (161:87)||2001|
acetylcholine receptor-inducing activity; alpha (45kD; ERBB2 p185-activator); glial growth factor; glial growth factor 2; heregulin; heregulin, alpha (45kD, ERBB2 p185-activator); membrane-bound isoform; neu differentiation factor; neuregulin 1 type III beta 3; pro-neuregulin-1; pro-neuregulin-1, membrane-bound isoform; pro-NRG1; sensory and motor neuron derived factor; type I neuregulin 1; type III neuregulin 1
6030402G23Rik; ARIA; D230005F13Rik; GGF; GGF2; GGFII; HGL; HRG; HRG1; HRGA; HRGalpha; MST131; MSTP131; NDF; NRG1; NRG1-IT2; SMDF